1. Johnson & Johnson Initiates Voluntarily Recall of a Single Lot of its Baby Powder in the US

Published: Oct 18, 2019 | Tags: JnJ, Initiates, Voluntarily, Recall, Baby Powder, US

2. AbbVie’s Rinvoq (Upadacitinib) Receives CHMP Positive Opinion to Treat Moderate to Severe Active Rheumatoid Arthritis

Published: Oct 18, 2019 | Tags: AbbVie, Rinvoq, Upadacitinib, Receives, CHMP, Positive Opinion, Treat, Moderate to Severe Active, Rheumatoid Arthritis

3. Merck’s V920 Ebola Zaire Vaccine Receives CHMP Positive Opinion to Protect Against Ebola Virus Disease

Published: Oct 18, 2019 | Tags: Merck, V920, Ebola Zaire Vaccine, Receives, CHMP, Positive Opinion, Protect, Against, Ebola Virus Disease

4. Cipla to Acquire Venus Remedies’ Elores to Strengthen its Critical Care Footprints in India

Published: Oct 17, 2019 | Tags: Cipla, Acquires, Venus Remedies, Elores, Strengthen, Presence Critical Care, India

5.Amgen and UCB’s Evenity (Romosozumab) Receive CHMP Positive Opinion to Treat Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture

Published: Oct 17, 2019 | Tags: Amgen, UCB, Evenity, Romosozumab, Receive, CHMP, Positive Opinion, Treat, Severe, Osteoporosis, Postmenopausal Women, High Risk of Fracture

6. Roche’s Xofluza (baloxavir marboxil) Receives the US FDA’s Approval for People at High Risk of Developing Influenza-Related Complications

Published: Oct 18, 2019 | Tags: Roche, Xofluza, baloxavir marboxil, Receives, US, FDA, Approval, People, Influenza-Related Complications

7. Fitbit Collaborates with BMS-Pfizer Alliance Focusing on Improving Atrial Fibrillation Detection

Published: Oct 17, 2019 | Tags: Fitbit, Collaborates, BMS-Pfizer Alliance, Focusing, Improving, Atrial Fibrillation Detection

8. UCB Reports Results of Bimekizumab in P-III BE VIVID Study to Treat Moderate to Severe Chronic Plaque Psoriasis

Published:  Oct 17, 2019 | Tags: UCB, Reports, Results, Bimekizumab, P-III, BE VIVID Study, Moderate to Severe Chronic, Plaque Psoriasis

9. Ipsen Signs Exclusive Worldwide License Agreement with Blueprint to Develop & Commercialize BLU-782 for Fibrodysplasia Ossificans Progressiva

Published: Oct 16, 2019 | Tags: Ipsen, Signs, Exclusive, Worldwide, License Agreement, Blueprint, Develop, Commercialize, BLU-782, Fibrodysplasia Ossificans Progressiva

10. Sun Pharma Launches Drizalma Sprinkle (duloxetine delayed-release capsules) for Neuro-Psychiatric and Pain Disorders in the US

Published: Oct 16, 2019 | Tags: Sun Pharma, Launches, Drizalma Sprinkle, duloxetine delayed-release capsules, Neuro-Psychiatric, Pain Disorders, US

11. AstraZeneca and Daiichi Report the US FDA’s Acceptance of BLA for Trastuzumab deruxtecan (DS-8201) and Granted Priority Review

Published: Oct 17, 2019 | Tags: AstraZeneca, Daiichi, Report, Acceptance, BLA, US, FDA, Trastuzumab deruxtecan, DS-8201, Priority Review

12. AstraZeneca Collaborates with PetaGene to Deploy PetaSuite in its Core Genomics Initiative

Published: Oct 16, 2019 | Tags: AstraZeneca, Collaborates, PetaGene, Deploy, PetaSuite, Core Genomics Initiative

13. Sandoz Terminates its Prescription Digital Therapies Agreement with Pear Therapeutics

Published: Oct 15, 2019 | Tags: Mitsubishi Tanabe, Signs, License Agreement, Viela Bio, Inebilizumab

14. Lilly Reports Results Pegilodecakin + Folfox in P-III SEQUOIA Study for Metastatic Pancreatic Cancer

Published: Oct 16, 2019 | Tags: Eli Lilly, Reports, Results, Pegilodecakin, Folfox, P-III, SEQUOIA Study, Metastatic Pancreatic Cancer

15. Alexion to Acquire Achillion for ~$930M

Published: Oct 16, 2019 | Tags: Alexion, Acquire, Achillion, ~$930M

16.ProQR’s Sepofarsen Receives FDA’s Rare Pediatric Disease Designation to Treat Leber’s Congenital Amaurosis 10

Published: Oct 15, 2019 | Tags: ProQR, Sepofarsen, Receives, FDA, Rare Pediatric Disease Designation, Leber’s Congenital Amaurosis 10

17.Daiichi Sankyo Acquires Rights for Astellas’ Three Therapies to Boost its Presence in Asia

Published: Oct 15, 2019 | Tags: Daichii Sankyo, Purchases, Astellas, Three Therapies, Boost, Presence, Asia

18. Sanofi and Kaken to Terminate their Co-Marketing Agreement for Clexane by the Year End 2019

Published: Oct 15, 2019 | Tags: Sanofi, Kaken, Terminate, Co-Marketing Agreement, Clexane, 2019

19. Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

Published: Oct 15, 2019 | Tags: Abbott, Tandem, Collaborate, Explore, Integrated Diabetes Solutions, Improving, Diabetes Management

20.Reata Reports Results of Omaveloxolone in P-II MOXIe Registrational Study for Patients with Friedreich’s Ataxia

Published: Oct 15, 2019 | Tags: Reata, Reports, Results, Omaveloxolone, P-II, MOXIe Registrational Study, Patients, Friedreich’s Ataxia

21. CRISPR Therapeutics and KSQ Therapeutics Cross Licenses their IP Rights to Facilitate Cell Therapy Programs in Oncology

Published: Oct 15, 2019 | Tags: CRISPR Therapeutics, KSQ Therapeutics, Sign, Cross Licensing Agreement, Facilitate, Cell Therapy Programs, Oncology

22. Kyowa Kirin Reports the Availability of Nourianz (Istradefylline) to Treat Parkinson’s Disease “Off” Episodes in the US

Published: Oct 14, 2019 | Tags:  Kyowa Kirin, Reports, Availability, Nourianz, Istradefylline, Parkinson’s Disease “Off” Episodes, US

23. Bayer and Janssen’s Xarelto (rivaroxaban) Receive FDA’s Approval to Prevent Venous Thromboembolism in Acutely Ill Patients

Published: Oct 14, 2019 | Tags: Bayer, Janssen, Xarelto, rivaroxaban, Receives, FDA, Approval Prevent, Venous Thromboembolism, Acutely Ill Patients

24. Abbott Collaborates with Omada Health to Provide Integrated Digital Health and Coaching Experience for Patients with Type 2 Diabetes

Published: Oct 14, 2019 | Tags: Abbott, Collaborates, Omada Health, Provide, Integrated Digital Health, Coaching Experience, Patients, Type 2 Diabetes

25. Takeda to Divest its Portfolio of Select OTC and Non-Core Assets to Acino for ~$200M in NEMEA Countries

Published: Oct 15, 2019 | Tags: Takeda, Divest, Select OTC, Non-Core Assets, Acino, Over $200M, NEMEA Countries

26. Sanofi Launches its First Digital Manufacturing Facility for Delivering Next-Generation Biologics in Massachusetts

Published: Oct 15, 2019 | Tags: Sanofi, Launches, First Digital Manufacturing Facility, Delivering, Next Generation Biologics, Massachusetts

27.Aytu BioScience to Acquire Cerecor’s Prescription Product Portfolio for $17M

Published: Oct 14, 2019 | Tags: Aytu BioScience, Acquire, Cerecor, Prescription Product Portfolio, $17M

28. Exact Sciences and Mayo Clinic Initiate Voyage Study Evaluating the Real-World Impact of Cologuard

Published: Oct 14, 2019 | Tags: Exact Sciences, Mayo Clinic, Initiate, Voyage Study, Evaluating, Real-World Impact, Cologuard

29. Lilly’s Reyvow (lasmiditan) Receives FDA’s Approval as the First Therapy in a New Class of Acute Treatment for Migraine

Published: Oct 11, 2019 | Tags: Lilly, Reyvow, lasmiditan, Receives, FDA, Approval, First Therapy, New Class, Acute Treatment Migraine

30. Roche Reports Results of MabThera/Rituxan (rituximab) in P-III PEMPHIX Study for Pemphigus Vulgaris

Published: Oct 14, 2019 | Tags: Roche, Reports, Results, MabThera/Rituxan, rituximab, P-III, PEMPHIX Study, Pemphigus Vulgaris

31. ImaginAb Collaborates with Three Global Pharmaceutical Companies Focusing on the Development of its CD8 ImmunoPET Technology

Published: Oct 14, 2019 | Tags: ImaginAb, Collaborates, Three, Global, Pharmaceutical Companies, Focusing, Development, CD8 ImmunoPET technology